You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

Profile for South Korea Patent: 101566840


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 101566840

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,486,941 Jan 3, 2030 Glaxosmithkline OJJAARA momelotinib dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Drug Patent KR101566840

Last updated: July 30, 2025


Introduction

Patent KR101566840 pertains to a pharmaceutical invention filed in South Korea, with focused claims surrounding a novel drug compound or formulation. Such patents typically aim to secure exclusive rights over specific chemical entities, formulations, or methods of use, which plays a critical role in the competitive landscape of pharmaceutical innovation. Understanding the scope of the claims and the broader patent landscape is vital for stakeholders, including bioscientists, legal professionals, and business strategists, to evaluate infringement risks, licensing opportunities, and freedom-to-operate considerations.


Scope of Patent KR101566840

1. Patent Classification and Focus

KR101566840 is classified under the International Patent Classification (IPC) codes relevant to pharmaceuticals, often within classes such as A61K (preparations for medicinal purposes) and C07D (heterocyclic compounds). These classifications suggest the patent relates either to a novel chemical entity, a drug formulation, or a therapeutic method.

2. Patent Claims Overview

The patent's claims delineate the scope of protection granted by the patent office. Typically, these include:

  • Compound Claim(s): A broad claim covering the novel chemical structure or class of compounds, possibly including specific substitutions or stereochemistry.

  • Method of Preparation: Claims may detail synthetic routes for the compound, establishing novelty and inventive step.

  • Therapeutic Use: Claims covering specific medical indications or methods of treatment using the compound.

  • Formulation and Delivery: Claims might extend to pharmaceutical formulations, including dosage forms, excipients, or delivery methods that enhance bioavailability or stability.

3. Claim Dependency and Breadth

In KR101566840, dependent claims likely narrow the scope by specifying particular substituents, stereoisomers, or specific formulations, while independent claims remain broad, aiming to cover a wide array of embodiments within the inventive concept. The breadth and language complexity influence the patent's enforceability and potential for infringement or workarounds.


Patent Landscape Analysis

1. Comparative Patents and Prior Art

A comprehensive landscape includes patents filed domestically and internationally that cover similar chemical scaffolds, mechanisms of action, or formulations. Notable considerations are:

  • Prior Art Search: Relevant prior art can include earlier patents, patent applications, scientific literature, or known compounds. The novelty of KR101566840 hinges upon specific structural features, synthesis methods, or therapeutic claims that distinguish it from prior art.

  • Overlap and Differentiation: The patent landscape suggests a high likelihood of overlapping claims with other compounds targeting the same indications (e.g., anti-inflammatory, anticancer). Differentiation points may include unique substituents, improved pharmacokinetics, or reduced side effects.

2. Domestic and International Patent Filings

South Korean firms, often in collaboration with international entities, tend to file patents in major jurisdictions such as the US, EU, and China. Corresponding patents or applications may reveal:

  • Aspects of the drug candidate with broader claims or alternative formulations.

  • Priority filings that establish territorial rights and influence patentability strategies.

3. Patent Term and Market Exclusivity

Given the filing date (assumed around the mid-2010s), the patent’s expiration date generally extends 20 years from the earliest priority date, subject to adjustments. Monitoring patent life is crucial for timing product launches and potential patent extensions through supplementary protections or data exclusivity.

4. Legal Status and Litigation

An analysis of legal status shows whether the patent remains active, has been challenged, or is subject to oppositions. Recently, South Korea’s patent authorities have processed invalidation claims or licensing disputes, especially in highly competitive areas like oncology or chronic disease therapeutics.


Implications for Stakeholders

1. For Innovators and R&D

The patent's scope indicates focus areas for developing new compounds or formulations within the protected scope or designing around claims to avoid infringement. Any narrow claims suggest a potential for designing alternative compounds.

2. For Generic Manufacturers

Understanding the breadth and claim scope enables generic manufacturers to analyze the risk of infringement and identify avenues for design-around strategies or licensing negotiations.

3. For Patent Holders

The patent landscape informs opportunities for licensing, patent thickets, or strategic patent acquisitions—particularly if the patent covers critical therapeutic classes.


Conclusion

Patent KR101566840 signifies a strategic intellectual property position within South Korea’s pharmaceutical sector. Its claims likely encompass a novel chemical entity with specific therapeutic use, supported by a landscape of similar patents that reflect active inventive efforts in this domain. The patent’s breadth and enforceability influence licensing potentials and market exclusivity, serving as a cornerstone for commercial development or strategic litigation.


Key Takeaways

  • KR101566840 likely covers a novel drug compound, method of synthesis, and therapeutic use, with claims carefully crafted to maximize scope while avoiding prior art.

  • The patent landscape surrounding this patent features overlapping patents in related drug classes, requiring precise analysis to assess freedom to operate.

  • Monitoring patent prosecution, legal status, and related filings aids in identifying opportunities and risks.

  • Companies should consider designing around narrow dependent claims or filing supplementary patents to strengthen their position.

  • Strategic patent management, including licensing negotiations and potential invalidation challenges, is essential to optimize commercial timelines.


FAQs

1. What types of claims are typically found in South Korean drug patents like KR101566840?
They usually include chemical compound claims, process claims for synthesis, use claims for specific indications, and formulation claims.

2. How can the scope of claims in KR101566840 influence competitive positioning?
Broader claims can extend market exclusivity but are more vulnerable to invalidation. Narrow claims limit coverage but are easier to defend.

3. What is the significance of related international patents in this landscape?
International filings can provide broad territorial protection, inform about global patent strategies, and impact the freedom to operate internationally.

4. How does patent term expiration affect drug development strategies?
Once the patent expires, generic competition arises, prompting firms to innovate or file new patents for extended protection.

5. What steps should stakeholders take to navigate the patent landscape of KR101566840?
Conduct comprehensive patent searches, monitor legal statuses, evaluate licensing options, and consider designing around narrow claims as appropriate.


References

  1. Korean Intellectual Property Office (KIPO) patent database.
  2. WIPO Patentscope.
  3. South Korea Patent Office Guidelines and Examination Procedures.
  4. Articles on pharmaceutical patent strategies and patent law in South Korea.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.